Sense announces initiation of clinical trial

Sense announces initiation of clinical trial

NEWS | Mar 16, 2021 Sense announces initiation of clinical trial to evaluate a non-invasive brain scanner to monitor intracranial hemorrhage SENSE device uses low-power tailored radio frequency (RF) pulse to detect changes that may indicate expanding brain bleed...
Sense announces initiation of clinical trial

2021 Emerging Medtech Summit Innovation Leader

NEWS | Feb 8, 2021 2021 Emerging Medtech Summit Innovation Leader Congratulations to Geoffrey Klass, CEO of Sense Neuro Diagnostics on being selected as an Innovation Leader at the LSI 2021 Emerging Medtech Summit. For the second year in a row, Geoff Klass will be...